Non-DM patients
|
Univariate linear regression
|
Multivariate linear regression (Mode A, R2 = 0.379)
|
Multivariate linear regression (Mode B, R2 = 0.373)
|
---|
Variables
|
Beta
|
95% CI
|
p-value
|
Beta
|
95% CI
|
p-value
|
Beta
|
95% CI
|
p-value
|
---|
Age
|
− 0.029
|
− 0.134 to 0.076
|
0.582
|
0.077
|
− 0.015 to 0.169
|
0.099
|
0.098
|
0.004 to 0.193
|
0.042
|
Sex
|
− 3.811
|
− 7.428 to − 0.193
|
0.039
|
− 4.107
|
− 7.250 to − 0.964
|
0.011
|
− 4.337
|
− 7.490 to − 1.183
|
0.007
|
BMI
|
0.463
|
− 0.003 to 0.928
|
0.051
|
0.286
|
− 0.109 to 0.680
|
0.155
|
0.318
|
− 0.078 to 0.714
|
0.115
|
Peak hs-CRP
|
− 0.152
|
− 0.304 to 0.001
|
0.051
|
− 0.185
|
− 0.312 to − 0.058
|
0.005
|
− 0.190
|
− 0.318 to − 0.063
|
0.004
|
Baseline LVEF
|
− 0.469
|
− 0.596 to − 0.342
|
< 0.001
|
− 0.492
|
− 0.614 to − 0.370
|
< 0.001
|
− 0.498
|
− 0.621 to − 0.375
|
< 0.001
|
Total ischemic time
|
− 0.004
|
− 0.012 to 0.004
|
0.318
|
− 0.005
|
− 0.011 to 0.001
|
0.114
|
− 0.005
|
− 0.011 to 0.002
|
0.148
|
No. of diseased vessels
|
− 0.516
|
− 1.958 to 0.927
|
0.481
|
− 0.171
|
− 1.364 to 1.022
|
0.778
|
− 0.174
|
− 1.374 to 1.026
|
0.775
|
ABG
|
− 0.866
|
− 1.634 to − 0.099
|
0.027
| | | |
− 1.124
|
− 1.795 to − 0.453
|
0.001
|
Glycemic gap
|
− 1.116
|
− 1.901 to − 0.331
|
0.006
|
− 1.214
|
− 1.886 to − 0.541
|
< 0.001
| | | |
- Change in LVEF was defined as LVEF at 6-month follow-up minus baseline LVEF
- DM diabetes mellitus, BMI body mass index, hs-CRP hypersensitive C-reactive protein, LVEF left ventricular ejection fraction, Total ischemic time the period from symptom onset to reopening of infarction-associated artery, ABG admission blood glucose